blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2325317

EP2325317 - Receptor nucleic acids and polypeptides [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  24.06.2016
Database last updated on 14.09.2024
Most recent event   Tooltip11.01.2019Change - lapse in a contracting statepublished on 13.02.2019  [2019/07]
Applicant(s)For all designated states
Biogen MA Inc.
250 Binney Street
Cambridge, MA 02142 / US
[2015/24]
Former [2011/21]For all designated states
Biogen Idec MA Inc.
14 Cambridge Center
Cambridge, Massachusetts 02142 / US
Inventor(s)01 / Ambrose, Christine M.
197 Wakefield St.
Reading, MA 01867 / US
02 / Thompson, Jeffrey
60 Newcomb Road
Stoneham, MA 02180 / US
 [2011/21]
Representative(s)Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[2016/30]
Former [2012/45]Pohlman, Sandra M.
df-mp Fünf Höfe Theatinerstrasse 16
80333 München / DE
Former [2011/21]Pohlman, Sandra M.
df-mp Fünf Höfe Theatinerstrasse 16
80333 München / DE
Application number, filing date10180786.506.09.2001
[2011/21]
Priority number, dateUS20000233152P18.09.2000         Original published format: US 233152 P
US20000243140P21.09.2000         Original published format: US 243140 P
US20010268499P13.02.2001         Original published format: US 268499 P
US20010312185P14.08.2001         Original published format: US 312185 P
[2011/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2325317
Date:25.05.2011
Language:EN
[2011/21]
Type: B1 Patent specification 
No.:EP2325317
Date:07.11.2012
Language:EN
[2012/45]
Type: B2 New European patent specification 
No.:EP2325317
Date:27.07.2016
Language:EN
[2016/30]
Search report(s)(Supplementary) European search report - dispatched on:EP20.04.2011
ClassificationIPC:C12N15/12, C12N15/62, C12N15/10, C12N5/10, C12P21/02, C07K14/715, C07K16/28, C07H21/04, C12Q1/68, A61K38/17, A61K48/00, G01N33/53, G01N33/68
[2011/21]
CPC:
C07K14/70578 (EP,CN,US); C12N15/1138 (NO); C12N15/11 (KR);
A61K48/00 (EP,NO,US); A61P13/12 (EP); A61P19/02 (EP);
A61P21/04 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P31/18 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P7/00 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/12 (EP); A61P9/14 (EP);
C07H21/04 (EP,US); C07K14/715 (NO); C07K14/7151 (EP,US);
C07K16/28 (NO); C07K16/2866 (EP,US); C07K16/2878 (EP,US);
C12N15/63 (NO); G01N33/53 (NO); G01N33/68 (CN,NO);
A61K38/00 (EP,CN,US); C07K2319/00 (EP,US); C07K2319/02 (CN);
C07K2319/30 (CN); G01N2333/70578 (CN); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2016/30]
Former [2011/21]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Rezeptor-Nukleinsäuren und -Polypeptide[2011/21]
English:Receptor nucleic acids and polypeptides[2011/21]
French:Récepteur d'acides nucléiques et polypeptides[2011/21]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure04.08.2011Observations by third parties
22.11.2011Amendment by applicant (claims and/or description)
22.11.2011Examination requested  [2011/52]
25.04.2012Communication of intention to grant the patent
22.08.2012Fee for grant paid
22.08.2012Fee for publishing/printing paid
Parent application(s)   TooltipEP01968621.1  / EP1352063
EP07105107.2  / EP1842918
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010968621) is  23.01.2006
Opposition(s)Opponent(s)01  02.08.2013    ADMISSIBLE
Schlich, George William
Schlich LLP
9 St Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
Opponent's representative
Schlich, George William, et al, et al
Schlich
9 St. Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
 [N/P]
Former [2013/37]
Opponent(s)01  02.08.2013    ADMISSIBLE
Schlich, George
Schlich LLP
9 St Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
Opponent's representative
Schlich, George, et al, et al
Schlich LLP
9 St Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
17.09.2013Invitation to proprietor to file observations on the notice of opposition
22.01.2014Reply of patent proprietor to notice(s) of opposition
07.10.2015Date of oral proceedings
19.11.2015Despatch of interlocutory decision in opposition
19.11.2015Despatch of minutes of oral proceedings
29.11.2015Legal effect of interlocutory decision in opposition
24.03.2016Despatch of communication that the patent will be maintained as amended
20.06.2016Fee for printing new specification paid
Fees paidRenewal fee
28.10.2010Renewal fee patent year 03
28.10.2010Renewal fee patent year 04
28.10.2010Renewal fee patent year 05
28.10.2010Renewal fee patent year 06
28.10.2010Renewal fee patent year 07
28.10.2010Renewal fee patent year 08
28.10.2010Renewal fee patent year 09
28.10.2010Renewal fee patent year 10
26.09.2011Renewal fee patent year 11
25.09.2012Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT07.11.2012
BE07.11.2012
CY07.11.2012
FI07.11.2012
IT07.11.2012
NL07.11.2012
TR07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
[2019/07]
Former [2017/12]AT07.11.2012
BE07.11.2012
CY07.11.2012
FI07.11.2012
IT07.11.2012
NL07.11.2012
TR07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2017/09]CY07.11.2012
FI07.11.2012
IT07.11.2012
NL07.11.2012
TR07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2015/32]CY07.11.2012
FI07.11.2012
IT07.11.2012
TR07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/52]CY07.11.2012
FI07.11.2012
IT07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/46]FI07.11.2012
IT07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/37]FI07.11.2012
IT07.11.2012
GR08.02.2013
PT07.03.2013
Former [2013/28]FI07.11.2012
GR08.02.2013
PT07.03.2013
Former [2013/24]FI07.11.2012
GR08.02.2013
Former [2013/22]FI07.11.2012
Documents cited:Search[A]WO0043032  (BIOGEN INC [US], et al);
by applicantEP0125023
 EP0171496
 EP0173494
 WO8601533
 EP0184187
 US4683195
 US4683202
 US4736866
 EP0264166
 WO8809810
 US4816567
 US4870009
 US4873316
 US4873191
 WO8910134
 US4946778
 WO9011354
 US4987071
 WO9101140
 US5116742
 WO9209689
 WO9304169
 US5223409
 US5225539
 US5272057
 US5283317
 WO9410300
 US5328470
 WO9416101
 US5459039
 US5493531
 US5541087
 US5703055
 US5726044
 WO1986US02269
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.